Topic: glioma
Contact: Scott Merville smerville@mdanderson.org 713-792-0661 University of Texas M. D. Anderson Cancer Center M. D. Anderson researchers discover mechanism that helps glioblastomas evade attack HOUST ... moreArk Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company"), announces that it has filed the formal request to the European Medicines Agency (EMEA) for re-examination of its marketing authorization ... more
Duke University Medical Center researchers have figured out how stem cells in the malignant brain cancer glioma may be better able to resist radiation therapy. And using a drug to block a particular s ... more
Duke University Medical Center researchers have figured out how stem cells in the malignant brain cancer glioma may be better able to resist radiation therapy. And using a drug to block a particular s ... more
Contact: Mary Jane Gore mary.gore@duke.edu 919-660-1309 Duke University Medical Center DURHAM, N.C. Duke University Medical Center researchers have figured out how stem cells in the malignant brain c ... more
Researchers have figured out how stem cells in the malignant brain cancer glioma may be better able to resist radiation therapy. And using a drug to block a particular signaling pathway in these cance ... more
By Mike Havrilla, ProActive Newsroom Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space such as Cell Genesys, Favrille ... more
Antigenics (NASDAQ: AGEN) announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitesp ... more
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, announced final results from its Phase 2 clinical study comparing the toxicity and overall surviv ... more
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, announced final results from its Phase 2 clinical study comparing the toxicity and overall surviv ... more
Survival is poor after second primary glioma in survivors of childhood cancer, according to a report in the September 28th Journal of Clinical Oncology. Reuters Health Information ... more
While little is known about the causes of glioma, researchers at the National Cancer Institute have found that this rare but often deadly form of brain cancer may be linked to early life physical acti ... more
While little is known about the causes of glioma, researchers at the National Cancer Institute have found that this rare but often deadly form of brain cancer may be linked to early life physical acti ... more
While little is known about the causes of glioma, researchers have found that this rare but often deadly form of brain cancer may be linked to early life physical activity and height. ... more
By Mike Havrilla MikeHavRx.com NeoPharm (OTC: NEOL.PK) is an emerging bio-pharmaceutical company focused on the development of anti-cancer agents based on two proprietary technology platforms that in ... more
Initial chemotherapy alone after surgery is just as successful as initial radiation therapy for patients from whom a very malignant brain tumor (anaplastic glioma) was removed. With this treatment, ... more
Initial chemotherapy alone after surgery is just as successful as initial radiation therapy for patients from whom a very malignant brain tumor (anaplastic glioma) was removed. With this treatment, ... more
Initial chemotherapy alone after surgery is just as successful as initial radiation therapy for patients from whom a very malignant brain tumor (anaplastic glioma) was removed, a new study has found. ... more
The recent death of Senator Ted Kennedy has focused new attention on brain cancer. Glioblastoma multiforme (GBM), the aggressive brain tumor that took Sen. Kennedy #8217;s life, is one of the deadli ... more
The malignant glioma responsible for the death of Senator Edward Kennedy, a remarkable man in anyone's estimation, followed a distinctly unremarkable course, cancer experts say. Medscape Medical N ... more
Having returned to his political career after treatment for a malignant glioma last year, the politician died earlier this morning. Medscape Medical News ... more
Elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein in human breast cancer are associated with unfavorable prognosis and progressive stages of disease. Researchers found increased e ... more
Study identifies pathway that helps control brain synapses BOSTON A form of partial epilepsy associated with auditory and other sensory hallucinations has been linked to the disruption of brain devel ... more
Elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein in human breast cancer are associated with unfavorable prognosis and progressive stages of disease. Researchers writing in the op ... more
Even low doses of radiotherapy that are regarded as safe may contribute to progressive cognitive decline in patients with low-grade glioma brain tumours, according to an Article published Online first ... more
Even low doses of radiotherapy that are regarded as safe may contribute to progressive cognitive decline in patients with low-grade glioma brain tumours, according to an Article published Online first ... more
An article published Online first and in an upcoming edition of The Lancet Neurology reports that although low doses of radiotherapy are considered as safe; they may contribute to progressive cognitiv ... more
An article published Online first and in an upcoming edition of The Lancet Neurology reports that although low doses of radiotherapy are considered as safe; they may contribute to progressive cognitiv ... more
Gliomas are among the most common and most malignant brain tumors. These tumors infiltrate normal brain tissue and grow very rapidly. As a result, surgery can never completely remove the tumor. Now, n ... more
The presence of 8 or more of 14 genetic variations conveys a 4-fold increase in glioma risk compared with in individuals who have a median number of these variants. Medscape Medical News ... more
For the first time, researchers have identified genetic variants commonly found in the population that can increase an individual's risk of developing glioma, the most prevalent brain tumour. The find ... more
For the first time, researchers have identified genetic variants commonly found in the population that can increase an individual's risk of developing glioma, the most prevalent brain tumour. The find ... more
Common genetic variations spread across five genes raise a person's risk of developing the most frequent type of brain tumor, an international research team reports online in Nature Genetics. Genet ... more
Clinical Study Shows Value Of Nexstim's Navigated Brain Stimulation (NBS) In Eloquent Cortex Surgery
The Burzynski Research Institute, Inc. (BRI) announced that it made three presentations of the results of phase II trials and mechanism of action data on it's antineoplaston A10 and antineoplaston AS2 ... more
The Burzynski Research Institute, Inc. (BRI) announced that it made three presentations of the results of phase II trials and mechanism of action data on it's antineoplaston A10 and antineoplaston AS2 ... more
Glioma is the most common and most serious form of brain tumors that affect adults. It has not yet been determined which specific type of cell in the brain is the source of the tumor, but now scientis ... more
The Burzynski Research Institute (BRI) announced positive safety and efficacy results in its Phase II clinical trial of Antineoplaston A10 and Antineoplaston AS2-1 therapy (ANP therapy) in children wi ... more
The Burzynski Research Institute (BRI) announced positive safety and efficacy results in its Phase II clinical trial of Antineoplaston A10 and Antineoplaston AS2-1 therapy (ANP therapy) in children wi ... more
The new technique "color-codes" tumors to help distinguish them from surrounding brain tissue. Medscape Medical News ... more
Antigenics Inc. (NASDAQ: AGEN) announced that Oncophage® (vitespen) has been granted orphan drug status for the treatment of glioma (brain cancer) by the US Food and Drug Administration (FDA). In Mar ... more
Antigenics Inc. (NASDAQ: AGEN) announced that Oncophage® (vitespen) has been granted orphan drug status for the treatment of glioma (brain cancer) by the US Food and Drug Administration (FDA). In Mar ... more
A new technique that measures vascular normalization on magnetic resonance imaging (MRI) can predict whether or not a patient with recurrent glioma will respond to anti-vascular endothelial growth fac ... more
In patients with recurrent malignant gliomas, correlation of response to low-dose fotemustine monotherapy with O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status may indicate th ... more
Hypofractionated stereotactic radiotherapy was well-tolerated and improved symptoms in patients with recurrent low-grade glioma, according to researchers from the Kimmel Cancer Center at Jefferson. Th ... more
Hypofractionated stereotactic radiotherapy was well-tolerated and improved symptoms in patients with recurrent low-grade glioma, according to researchers from the Kimmel Cancer Center at Jefferson. Th ... more
Hypofractionated Stereotactic Radiotherapy Beneficial For Recurrent Low-grade Glioma, Study Suggests
Ark Therapeutics Group plc (AKT:LSE) ("Ark" or "the Company") is pleased to announce that it has completed the first update of the results of its Cerepro® Phase III trial (Study 904) in accordance w ... more
Ark Therapeutics Group plc (AKT:LSE) ("Ark" or "the Company") is pleased to announce that it has completed the first update of the results of its Cerepro® Phase III trial (Study 904) in accordance w ... more
The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumors showed it was safe and effective at delaying tumor progression, according to a retrospective study of 22 patients conduct ... more
Scientists at Duke University Medical Center and Johns Hopkins University have discovered mutations in two genes that could become therapeutic targets in malignant glioma, a dangerous class of brain t ... more
Ark Therapeutics Group plc ("Ark" or the "Company") (AKT:LSE) today announces that the first Named Patient Supply (NPS) for Cerepro® has been approved by the French Medicines Control Agency (AFSSAPS) ... more
Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") is pleased to announce today that the Marketing Authorisation Application (MAA) for Cerepro®, Ark's novel gene-based therapy for operabl ... more
Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") today announces that the Marketing Authorisation Application (MAA) for Cerepro®, Ark's novel gene-based therapy for operable malignant g ... more
Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") today announces that the Marketing Authorisation Application (MAA) for Cerepro®, Ark's novel gene-based therapy for operable malignant g ... more
Today at the 13th Annual Scientific Meeting of the Society for Neuro-Oncology, BRI announced encouraging results from the ongoing Phase II clinical trials of two of its investigational drugs, Atengena ... more
Today at the 13th Annual Scientific Meeting of the Society for Neuro-Oncology, BRI announced encouraging results from the ongoing Phase II clinical trials of two of its investigational drugs, Atengena ... more
An anti-brain tumor agent developed from a genetically engineered herpes simplex virus has been shown to be safe when given in two doses and injected directly into the brain of patients with malignant ... more
An anti-brain tumor agent developed from a genetically engineered herpes simplex virus has been shown to be safe when given in two doses and injected directly into the brain of patients with malignant ... more
Scientists have developed a new drug delivery system that is capable of crossing the blood-brain barrier to reach and kill cancer cells in the brain. Following successful preclinical studies, the tech ... more
Scientists have developed a new drug delivery system that is capable of crossing the blood-brain barrier to reach and kill cancer cells in the brain, according to research presented at the 20th EORTC- ... more
A multi-institutional study led by researchers at The University of Texas M. D. Anderson Cancer Center has found that using chemotherapy alone and delaying or avoiding cranial radiation altogether can ... more
A multi-institutional study led by researchers at The University of Texas M. D. Anderson Cancer Center has found that using chemotherapy alone and delaying or avoiding cranial radiation altogether can ... more
A new study has found that using chemotherapy alone and delaying or avoiding cranial radiation altogether can be effective in treating pediatric patients with unresectable or progressive low-grade gli ... more
TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced today that dosing was initiated in a Phase 1/2 trial of 131I-TM601 delivered intravenously (IV) for th ... more
TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced today that dosing was initiated in a Phase 1/2 trial of 131I-TM601 delivered intravenously (IV) for th ... more
Ark Therapeutics Group plc (AKT:LSE) announces that the preliminary analysis of Study 904, a Phase III study of Cerepro (R), its novel gene-based therapy being developed as an Orphan Drug for the trea ... more
Ark Therapeutics Group plc (AKT:LSE) announces that the preliminary analysis of Study 904, a Phase III study of Cerepro (R), its novel gene-based therapy being developed as an Orphan Drug for the trea ... more
Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based Medicine Project. The project is a national consortium of cutting- ... more
Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based Medicine Project. The project is a national consortium of cutting- ... more
Tests show success, but general use not yet approved Viruses aren #8217;t always the bad guys. Sure, they can cause colds, measles, AIDS and other miseries. But with some tinkering, these tiny organis ... more
Senator Edward Kennedy had a successful three and a half hour operation to remove a brain tumour yesterday, the first step in his treatment for brain cancer, said his doctors.Two weeks ago, according ... more
"A two-year survival rate of more than 80 percent in recurrent or refractory anaplastic astrocytoma suggests a breakthrough in this devastating disease by targeted therapy," commented Prof. Ulrich Bog ... more
TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced the initiation of a Phase 1 trial to test the safety, tolerability, dosing and pharmacokinetics of non ... more
TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced the initiation of a Phase 1 trial to test the safety, tolerability, dosing and pharmacokinetics of non ... more
He has a malignant glioma, an especially lethal type of brain tumor ... more
St. Jude Children's Research Hospital investigators have shown that children under 3 years old who have a brain tumor called diffuse pontine glioma (DPG) appear to have a better outcome than older c ... more
St. Jude Children's Research Hospital investigators have shown that children under 3 years old who have a brain tumor called diffuse pontine glioma (DPG) appear to have a better outcome than older c ... more
Investigators have shown that children under 3 years old who have a brain tumor called diffuse pontine glioma appear to have a better outcome than older children with the same cancer. ... more
Late cognitive decline is not related to previous cardiopulmonary bypass in CAD patients, Senator Edward Kennedy has a malignant glioma, moderate alcohol use associated with lower hip-fracture risk, c ... more
Sen. Kennedy is now home awaiting decisions on his treatment course after diagnosis of a malignant glioma earlier this week. Medscape Medical News ... more
Oncolab, Inc.'s AMAS(R) Test (http://www.oncolabinc.com) is a commercially available blood test that may allow early detection of a wide range of human cancers. It detects a circulating, cancer-speci ... more
Oncolab, Inc.'s AMAS(R) Test (http://www.oncolabinc.com) is a commercially available blood test that may allow early detection of a wide range of human cancers. It detects a circulating, cancer-speci ... more
A grim diagnosis.Someone in the comments here called it early. Seizures and headaches are two of the most common presenting symptoms.Treatment options would included a combined approach of post-opera ... more
Democrat US Senator Edward Kennedy has a type of brain tumor known as a glioma, his doctors told the press yesterday, Tuesday, from Massachusetts General Hospital, Boston, where the 76 year old Kenned ... more
Democrat US Senator Edward Kennedy has a type of brain tumor known as a glioma, his doctors told the press yesterday, Tuesday, from Massachusetts General Hospital, Boston, where the 76 year old Kenned ... more
Doctors find malignant glioma in tests after seizure ... more
Fox News is reporting that Sen. Edward M. Kennedy has a malignant brain tumor. Doctors for the senator say tests conducted after he suffered a seizure this weekend show a tumor in his left parietal lo ... more
Recent discoveries about the role of stem cells in cancer have altered the landscape of cancer research. As scientists learn more their cancer-initiating properties, stem cells are emerging as potenti ... more
Identification of cancer stem cells remains a challenge at the microscopic level, but researchers have concluded that low proteosome activity can be an effective marker to isolate these cells from the ... more
Identification of cancer stem cells remains a challenge at the microscopic level, but researchers have concluded that low proteosome activity can be an effective marker to isolate these cells from the ... more
Recent discoveries about the role of stem cells in cancer have altered the landscape of cancer research. As scientists learn more their cancer-initiating properties, stem cells are emerging as potenti ... more
Mitsugu Fujita, M.D., Ph.D., and Ryo Ueda, M.D., Ph.D., both researchers with the University of Pittsburgh Cancer Institute's (UPCI) Brain Tumor Program, are pursuing the same aim: understanding the b ... more
Mitsugu Fujita, M.D., Ph.D., and Ryo Ueda, M.D., Ph.D., both researchers with the University of Pittsburgh Cancer Institute's (UPCI) Brain Tumor Program, are pursuing the same aim: understanding the b ... more
BiPar Sciences, Inc. announced the expansion of the clinical program for the company's lead product candidate, BSI-201, into glioblastoma multiforme (GBM), the most common glioma in adults. ... more
BiPar Sciences, Inc. announced the expansion of the clinical program for the company's lead product candidate, BSI-201, into glioblastoma multiforme (GBM), the most common glioma in adults. BSI-201, ... more
Glioblastomas are the most common and most malignant type of glioma. Healthcare professionals face many challenges in the treatment of glioblastoma as therapy remains largely palliative, and mean leng ... more
Glioblastomas are the most common and most malignant type of glioma. Healthcare professionals face many challenges in the treatment of glioblastoma as therapy remains largely palliative, and mean leng ... more